Uniunea Europeană - română - EMA (European Medicines Agency)

sanofi winthrop industrie - lixisenatide - diabetul zaharat, tip 2 - drugs used in diabetes, glucagon-like peptide-1 (glp-1) analogues - lyxumia is indicated for the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with oral glucose lowering medicinal products and/or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control.

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sanofi-aventis deutschland gmbh - germania - lixisenatidum - sol. inj. - 100 µg/ml - analogi ai glp-1 antidiabetice injectabile